Heading into the J.P. Morgan Healthcare Conference, the conversation will center on accelerated deal flow, selective but improving capital access, and disciplined execution. Strategic buyers face patent cliffs and pipeline gaps, investors are seeking risk‑adjusted structures, and operators are focused on manufacturing readiness and payer dynamics….
By: Foley Hoag LLP
By: Foley Hoag LLP
